Assignee
UCL BUSINESS LTD
GB·91 granted patents·170 pending applications·63 citations·filing 2012–2025
Top patents by PatentIndex Score
261 records- 0192US10730942B2Protein-based T-cell receptor knockdownUCL BUSINESS LTD·Filed 2017·Granted Aug 4, 2020·15 cites·4 claims
- 0288US11723925B2ROR1 CAR T-cellsUCL BUSINESS LTD·Filed 2018·Granted Aug 15, 2023·6 cites·16 claims
- 0388US2025108093A1Factor VIII SequencesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 0487US11517631B2Factor IX encoding nucleotidesUCL BUSINESS LTD·Filed 2019·Granted Dec 6, 2022·2 cites·14 claims
- 0587US11306142B2Bispecific antibodies to ROR1 and CD3UCL BUSINESS LTD·Filed 2018·Granted Apr 19, 2022·5 cites·16 claims
- 0686US11466083B2ROR1 antibodiesUCL BUSINESS LTD·Filed 2018·Granted Oct 11, 2022·4 cites·19 claims
- 0784US2025057798A1Therapeutic use of compoundsUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 0883US2025270279A1Polypeptide useful in adoptive cell therapyUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 0982US10925943B2Marker-suicide gene useful in adoptive cell therapyUCL BUSINESS LTD·Filed 2013·Granted Feb 23, 2021·3 cites·12 claims
- 1081US12090131B2Therapeutic use of compoundsUCL BUSINESS LTD·Filed 2022·Granted Sep 17, 2024·0 cites·1 claims
- 1181US10792395B2Methods and devices for the production of decellularised tissue scaffoldsUCL BUSINESS LTD·Filed 2016·Granted Oct 6, 2020·4 cites·32 claims
- 1280US11387479B2Flow batteries with current collectors having a dielectric coatingUCL BUSINESS LTD·Filed 2019·Granted Jul 12, 2022·2 cites·17 claims
- 1380US2023241180A1Factor VIII SequencesUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 1480US2024293580A1Optimized RPE65 Promoter and Coding SequencesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 1579US10842885B2Factor IX encoding nucleotidesUCL BUSINESS LTD·Filed 2018·Granted Nov 24, 2020·2 cites·24 claims
- 1678US11939220B2Nanomaterial preparation methodUCL BUSINESS LTD·Filed 2019·Granted Mar 26, 2024·2 cites·25 claims
- 1778US11643451B2T cell receptorUCL BUSINESS LTD·Filed 2017·Granted May 9, 2023·3 cites·11 claims
- 1878US2024384301A1Method for enhancing the suppressive properties of treg cellsUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 1978US2024400513A1Novel compoundsUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2078US2025066472A1Ror1 antibodiesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2177US2024372162A1Method of enhancing electrochemical cell performanceUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2277US2025129065A1Substituted naphthalene diimides and their useUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2376US11491127B2Therapeutic use of compoundsUCL BUSINESS LTD·Filed 2019·Granted Nov 8, 2022·0 cites·3 claims
- 2476US11419839B2Therapeutic use of compoundsUCL BUSINESS LTD·Filed 2019·Granted Aug 23, 2022·0 cites·5 claims
- 2576US10611811B2LigandUCL BUSINESS LTD·Filed 2017·Granted Apr 7, 2020·1 cites·15 claims
- 2676US10568973B2Optimized RPE65 promoter and coding sequencesUCL BUSINESS LTD·Filed 2016·Granted Feb 25, 2020·2 cites·21 claims
- 2775US12227756B2Engineered regulatory T cellUCL BUSINESS LTD·Filed 2019·Granted Feb 18, 2025·1 cites·11 claims
- 2875US11919856B2CompoundsUCL BUSINESS LTD·Filed 2022·Granted Mar 5, 2024·0 cites·23 claims
- 2975US11693013B2Method relating to myostatin pathway inhibitionUCL BUSINESS LTD·Filed 2018·Granted Jul 4, 2023·1 cites·76 claims
- 3075US10933142B2Reversible covalent linkage of functional moleculesUCL BUSINESS LTD·Filed 2019·Granted Mar 2, 2021·0 cites·7 claims
- 3175US2023212166A1Substituted naphthalene diimides and their useUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 3275US2024156926A1Polypeptide useful in adoptive cell therapyUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 3374US11419920B2Factor VIII sequencesUCL BUSINESS LTD·Filed 2020·Granted Aug 23, 2022·0 cites·9 claims
- 3474US10980632B2Prosthetic heart valveUCL BUSINESS LTD·Filed 2016·Granted Apr 20, 2021·5 cites·14 claims
- 3574US2024076696A1Gene therapy composition and treatment of right ventricular arrhythmogenic cardiomyopathyUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 3673US10500139B2Formulations and materials with cationic polymersUCL BUSINESS LTD·Filed 2014·Granted Dec 10, 2019·1 cites·20 claims
- 3773US2023273221A1Method relating to myostatin pathway inhibitionUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 3872US2025334590A1Method relating to myostatin pathway inhibitionUCL BUSINESS LTD·Filed 2025·Application pending·0 cites
- 3971US12257319B2Optimised coding sequence and promoterUCL BUSINESS LTD·Filed 2020·Granted Mar 25, 2025·0 cites·20 claims
- 4071US10874611B2Chemotactic, drug-containing polymersomesUCL BUSINESS LTD·Filed 2017·Granted Dec 29, 2020·1 cites·9 claims
- 4170US12467066B2Compositions and methods for treating retinal disordersUCL BUSINESS LTD·Filed 2023·Granted Nov 11, 2025·0 cites·29 claims
- 4270US2025057899A1Gene therapy for ciliopathiesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 4370US2025326808A1Treatment of the corneal endotheliumUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 4470US2023220073A1Ror1 antibodiesUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 4569US12077774B2Method for enhancing the suppressive properties of Treg cellsUCL BUSINESS LTD·Filed 2019·Granted Sep 3, 2024·0 cites·10 claims
- 4669US11006881B2Detecting activity in peripheral nervesUCL BUSINESS LTD·Filed 2016·Granted May 18, 2021·2 cites·20 claims
- 4769US2025290096A1Gene therapy to improve visionUCL BUSINESS LTD·Filed 2025·Application pending·0 cites
- 4869US2022331409A1Factor ix gene therapyUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 4969US2024165043A1Compositions for the treatment of a disease of the urinary tract and treatment of a disease involving the intracellular delivery of the particle or a medicament contained thereinUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 5069US2025052737A1Trigger-assembled membrane-spanning nucleic acid nanostructuresUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
Showing the top 50 of 261 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when UCL BUSINESS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →